Total submissions: 30
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000211645 | SCV002506376 | likely benign | Hypercholesterolemia, familial, 1 | 2022-03-16 | reviewed by expert panel | curation | The NM_000527.5(LDLR):c.1706-10G>A variant is classified as Likely benign for Familial Hypercholesterolemia by applying evidence codes BS1, BS3_supporting and PP1_moderate as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: BS1 - FAF = 0.002911 (0.2911%) in Latino/Admixed American exomes (gnomAD v2.1.1), so BS1 is Met. BS3_supporting - 2 Level 3 assays: PMID: 25741862: Heterozygous patients' lymphocytes, RNA assays - result - Normal LDLR transcripts identified by sequencing. PMID: 19208450: Heterozygous patients' Epstein Barr virus transformed lymphocytes, RNA assays - result - Normal LDLR transcripts, 43% of mutant transcripts (from total transcripts) in htz cells. ---- Aberrant transcripts are not detected, so BS3_Supporting is Met. PP1_moderate - Variant segregates with FH phenotype in at least 5 informative meiosis from 2 families from Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge: 5 affected family members have the variant, so PP1_Moderate is Met. Variant has 1 Strong plus 1 Supporting evidence codes towards Benign, enough to classify as Likely benign and only 1 Moderate evidence code towards Pathogenic, not enough for Likely pathogenic, so we are confident in classifying this variant as Likely benign. |
LDLR- |
RCV000211645 | SCV000295599 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Cardiovascular Research Group, |
RCV000211645 | SCV000322971 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | 1/125 non-FH individuals |
Cardiovascular Biomarker Research Laboratory, |
RCV000211645 | SCV000323103 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-08-31 | criteria provided, single submitter | research | MAF =<0.3%, LDL-C >=160 mg/dL |
Centre de Génétique Moléculaire et Chromosomique, |
RCV000211645 | SCV000503394 | benign | Hypercholesterolemia, familial, 1 | 2016-12-16 | criteria provided, single submitter | clinical testing | subjects mutated among 2600 FH index cases screened = 15 |
Laboratory for Molecular Medicine, |
RCV000455738 | SCV000539506 | likely benign | not specified | 2017-02-03 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This is an intronic variant in LDLR. It is classified as DM? in HGMD. It has been reported in 2 probands with hypercholesterolemia but in both co-occurred with another variant. It is classified in ClinVar with 1 star as Benign by Cardiovascular Genetics Laboratory,PathWest Laboratory Medicine WA - Fiona Stanley Hospital, Likely benign by British Heart Foundation and Instituto Nacional de Saude Doutor Ricardo Jorge (in 1/125 non-FH individuals), and as VUS by CHOP. It has a max MAF in ExAC of 0.38% (44 Latino alleles) and in gnomAD of 0.4% (41 Ashkenazi and 122 Latino alleles). |
Labcorp Genetics |
RCV000771093 | SCV000556772 | benign | Familial hypercholesterolemia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
U4M - |
RCV000211645 | SCV000583867 | likely benign | Hypercholesterolemia, familial, 1 | 2017-03-30 | criteria provided, single submitter | clinical testing | |
Laboratory of Genetics and Molecular Cardiology, |
RCV000211645 | SCV000588603 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Fundacion Hipercolesterolemia Familiar | RCV000211645 | SCV000607628 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Color Diagnostics, |
RCV000771093 | SCV000689765 | benign | Familial hypercholesterolemia | 2022-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000455738 | SCV000730511 | benign | not specified | 2017-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Iberoamerican FH Network | RCV000211645 | SCV000748152 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Robarts Research Institute, |
RCV000211645 | SCV000782923 | likely benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759075 | SCV000888162 | benign | not provided | 2022-05-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771093 | SCV000902688 | benign | Familial hypercholesterolemia | 2018-06-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000211645 | SCV001281863 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000759075 | SCV001747208 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | LDLR: BP4, BS1 |
Ambry Genetics | RCV002399781 | SCV002712874 | benign | Cardiovascular phenotype | 2021-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000211645 | SCV002804653 | likely benign | Hypercholesterolemia, familial, 1 | 2022-04-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000759075 | SCV004564798 | benign | not provided | 2023-11-08 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000771093 | SCV005073993 | benign | Familial hypercholesterolemia | 2022-07-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000759075 | SCV005312108 | benign | not provided | criteria provided, single submitter | not provided | ||
Cardiovascular Genetics Laboratory, |
RCV000211645 | SCV000268631 | benign | Hypercholesterolemia, familial, 1 | 2015-04-02 | no assertion criteria provided | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000211645 | SCV000296925 | uncertain significance | Hypercholesterolemia, familial, 1 | 2015-09-02 | flagged submission | clinical testing | |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000211645 | SCV000606493 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research | ||
Diagnostic Laboratory, |
RCV000211645 | SCV000733826 | likely benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000455738 | SCV001922575 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000759075 | SCV001975804 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000771093 | SCV002086435 | likely benign | Familial hypercholesterolemia | 2019-11-06 | no assertion criteria provided | clinical testing |